Duration of efficacy of treatment of latent tuberculosis infection in HIV-infected adults-Reference-Cited by-同舟云学术

Duration of efficacy of treatment of latent tuberculosis infection in HIV-infected adults

Published:2001-11 Issue:16 Volume:15 Page:2137-2147
ISSN:0269-9370
Container-title:AIDS
language:en
Short-container-title:AIDS

Author:

Johnson John L.,Okwera Alphonse,Hom David L.,Mayanja Harriet,Kityo Cissy Mutuluuza,Nsubuga Peter,Nakibali Joseph G.,Loughlin Anita M.,Yun Hyun,Mugyenyi Peter N.,Vernon Andrew,Mugerwa Roy D.,Ellner Jerrold J.,Whalen Christopher C.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Infectious Diseases,Immunology,Immunology and Allergy

Reference31 articles.

1. The In Vitro Induction of Human Immunodeficiency Virus (HIV) Replication in Purified Protein Derivative‐Positive HIV‐Infected Persons by Recall Antigen Response toMycobacterium tuberculosisIs the Result of a Balance of the Effects of Endogenous Interleukin‐2 and Proinflammatory and Antiinflammatory Cytokines

2. A Prospective Study of Tuberculosis and HIV Disease Progression

3. Impact of pulmonary tuberculosis on survival of HIV-infected adults: a prospective epidemiologic study in Uganda

4. A Controlled Trial of Isoniazid in Persons with Anergy and Human Immunodeficiency Virus Infection Who Are at High Risk for Tuberculosis

5. Rifampin and Pyrazinamide vs Isoniazid for Prevention of Tuberculosis in HIV-Infected PersonsAn International Randomized Trial

Cited by 129 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy of anti-tuberculosis drugs for the treatment of latent tuberculosis infection: a systematic review and network meta-analysis;Scientific Reports;2023-09-27

2. Completion, safety, and efficacy of tuberculosis preventive treatment regimens containing rifampicin or rifapentine: an individual patient data network meta-analysis;The Lancet Respiratory Medicine;2023-09

3. Efficacy and safety of different regimens in the treatment of patients with latent tuberculosis infection: a systematic review and network meta-analysis of randomized controlled trials;Archives of Public Health;2023-05-05

4. Latent tuberculosis infection therapy in people living with human immunodeficiency virus infection;2023-03-30

5. Efficacy, safety, and tolerability of isoniazid preventive therapy for tuberculosis in people living with HIV;AIDS;2022-11-22